Note 8 - Sale of Common Stock (Details) (USD $)	1 Months Ended		3 Months Ended		12 Months Ended		1 Months Ended	9 Months Ended	1 Months Ended	9 Months Ended			1 Months Ended		2 Months Ended		1 Months Ended		12 Months Ended		12 Months Ended		1 Months Ended	10 Months Ended	12 Months Ended		12 Months Ended
	Sep. 30, 2013	Feb. 28, 2013	Dec. 31, 2013	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2013 September 2013 SPA [Member] Warrant Issued For Placement Agent Services [Member]	Sep. 30, 2013 September 2013 SPA [Member] September 2013 Warrants [Member]	Sep. 30, 2013 September 2013 SPA [Member] September 2013 Warrants [Member]	Sep. 30, 2013 September 2013 SPA [Member]	Sep. 30, 2013 September 2013 SPA [Member]	Dec. 31, 2013 September 2013 SPA [Member]	Feb. 28, 2013 February 2013 SPA [Member] Warrant Issued For Placement Agent Services [Member]	Feb. 28, 2013 February 2013 SPA [Member] February 2013 Warrants [Member]	Feb. 28, 2013 February 2013 SPA [Member]	Feb. 28, 2013 February 2013 SPA [Member]	Dec. 31, 2013 February 2013 SPA [Member]	Feb. 28, 2013 Additional Issurance Due To Anti-Dilutive Provisions [Member]	Dec. 31, 2013 February 2013 SPA Option [Member]	Dec. 31, 2013 September 2013 Warrants [Member]	Sep. 18, 2013 September 2013 Warrants [Member]	Dec. 31, 2013 September 2013 SPA Option [Member]	Sep. 18, 2013 September 2013 SPA Option [Member]	Feb. 28, 2013 February 2013 Warrants [Member]	Dec. 31, 2013 February 2013 Warrants [Member]	Dec. 31, 2013 February 2013 Warrants [Member]	Feb. 22, 2013 February 2013 Warrants [Member]	Dec. 31, 2013 February 2013 SPA Option [Member]	Feb. 22, 2013 February 2013 SPA Option [Member]
Note 8 - Sale of Common Stock (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)									29,166,668						26,933,333		40,400,001
Sale of Stock, Price Per Share (in Dollars per share)									$ 0.06	$ 0.06				$ 0.15	$ 0.15
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)						1,485,333	30,625,001	30,625,001	29,166,668	29,166,668		1,885,333	28,818,666	26,933,333	26,933,333
Proceeds from Issuance or Sale of Equity									$ 1,750,000						$ 4,040,000
Proceeds from Issuance or Sale of Equity, Net									1,575,000						3,504,000
Term To Hold Share Purchase									24 months					24 months
(in Shares)			35,666,000		35,666,000				16,666,667	16,666,667				7,000,000	7,000,000
Right To Purchase Common Stock Shares (in Shares)									16,666,667					7,000,000
Delivery Period for Common Shares Upon Investors' Request	3 days													3 days
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)			35,666,000		35,666,000						16,666,667					19,000,000
Percentage of Common Shares Available for Purchase at Initial Closing										50.00%				50.00%
Class of Warrant or Right Exercise Period of Warrants or Rights								5 years						5 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)							0.08	0.08					0.20						0.08	0.08	0.06	0.06		0.08	0.08	0.20		0.15
Class of Warrant or Right Period for Presenting Effective Registration Statement for Avoiding Cashless Exercise of Warrants or Rights							180 days						180 days
Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants							4.99%	4.99%					4.99%
Discretionary Increase in Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants							9.99%	9.99%					9.99%
Notice Period for Discretionary Increase in Limitation of Beneficially Owned Percentage of Common Stock for Exercise of Warrants							61 days						61 days
Warrants Grant Date Fair Value																		1,211,000	1,807,000		1,166,000			2,759,000	2,759,000
Derivative Liability, Fair Value, Gross Liability																			627,000		292,000			1,441,000	1,441,000		0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings																			1,180,000		874,000				1,318,000		1,211,000
(in Shares)			35,666,000		35,666,000				16,666,667	16,666,667				7,000,000	7,000,000
(in Shares)																							43,228,001	43,228,001
(in Dollars per share)																							$ 0.08	$ 0.08
Net Proceeds Used For Investor Relations					1,000,000
Payments For Investor Relations		500,000	220,000	250,000
Restricted Cash and Cash Equivalents, Current			30,000		30,000
Investor Relations Payments Amortization Period					1 year
Investor Relations Services Aggregate Fees					$ 970,000